A Pilot Study of MK-3475 With Cryotherapy for Men With Newly Diagnosed Oligo-metastatic Prostate Cancer

Trial Profile

A Pilot Study of MK-3475 With Cryotherapy for Men With Newly Diagnosed Oligo-metastatic Prostate Cancer

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 24 Nov 2016

At a glance

  • Drugs Pembrolizumab (Primary) ; Degarelix
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 21 Nov 2016 Status changed from recruiting to active, no longer recruiting.
    • 10 Nov 2015 Planned primary completion date changed from 1 Dec 2018 to 1 Nov 2018, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top